Article
Deletions of specific exons of FHOD3 detected by next-generation sequencing are associated with hypertrophic cardiomyopathy.
Clinical genetics - 1 Jul 2020
Ochoa Juan P, Lopes Luis R, Perez-Barbeito Marlene, Cazón-Varela Laura, de la Torre-Carpente Maria M, Sonicheva-Paterson Natalia, De Uña-Iglesias David, Quinn Ellen, Kuzmina-Krutetskaya Svetlana, Garrote José A, Elliott Perry M, Monserrat Lorenzo
Abstract excerpt
Despite new strategies, such as evaluating deep intronic variants and new genes in whole-genome-sequencing studies, the diagnostic yield of genetic testing in hypertrophic cardiomyopathy (HCM) is still around 50%. FHOD3 has emerged as a novel disease-causing gene for this phenotype, but the relevance and clinical implication of copy-number variations (CNVs) have not been determined. In this study, CNVs were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
